AVNT 8-K/A
Avient Corp (AVNT)
8-K/A
2022-11-07
For: 2022-08-29
View Original
Added on
April 08, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 29, 2022
| (Exact Name of Registrant as Specified in Its Charter) | ||||||||
| | ||||||||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (440 ) 930-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
EXPLANATORY NOTE
This Amendment No. 1 to the Current Report on Form 8-K, which was originally filed with the Securities and Exchange Commission on September 1, 2022 (the “Original 8-K”), amends and restates in its entirety Item 9.01 of the Original 8-K to include certain pro forma financial information required by Item 9.01 of Form 8-K in connection with (i) the acquisition by Avient Corporation (“Avient”) from Koninklijke DSM N.V. (“Seller”) of (a) all of the equity of DSM Protective Materials International B.V., DSM Protective Materials B.V. and DSM Protective Materials LLC and (b) certain other assets related to Seller’s protective materials business (such equity and assets together, the “DPM Business”) (such acquisition of the DPM Business, the “Acquisition”) and (ii) Avient’s then-pending disposition of its Distribution business. The remainder of the information contained in the Original 8-K is not hereby amended.
Item 9.01 Financial Statements and Exhibits.
(a) Financial Statement of Business Acquired.
Avient previously provided the financial statements required by Item 9.01(a) of Form 8-K as Exhibit 99.1 to its Current Report on Form 8-K filed on August 3, 2022.
(b) Pro Forma Financial Information.
Avient previously provided the pro forma financial statements giving effect to the Acquisition as Exhibit 99.2 to its Current Report on Form 8-K filed on August 3, 2022. Unaudited pro forma financial information giving effect to the Acquisition and the disposition of Avient’s Distribution business is attached as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated in this Item 9.01(b) by reference.
(d) Exhibits:
| Number | Exhibit | ||||
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. | ||||
† The exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided to the Securities and Exchange Commission upon request.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AVIENT CORPORATION
By: /s/ Lisa K. Kunkle
Name: Lisa K. Kunkle
Title: Senior Vice President, General Counsel & Secretary
Dated: November 7, 2022